Literature DB >> 22945326

HDL cholesterol is not HDL--don't judge the book by its cover.

Benoit J Arsenault1, Jean-Pierre Després.   

Abstract

The concept that raising HDL-cholesterol level will uniformly translate into cardiovascular risk reduction has been challenged by genetic epidemiology studies and large-scale, randomized clinical trials. Studies suggest that we should go beyond HDL cholesterol, and consider emerging biomarkers of HDL concentration, composition, and functionality as surrogates for cardiovascular risk reduction.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22945326     DOI： 10.1038/nrcardio.2012.127

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


  9 in total

1.  Quantification of plasma lipoproteins by proton nuclear magnetic resonance spectroscopy.

Authors:  J D Otvos; E J Jeyarajah; D W Bennett
Journal:  Clin Chem       Date:  1991-03       Impact factor: 8.327

2.  Effect of dalcetrapib plus pravastatin on lipoprotein metabolism and high-density lipoprotein composition and function in dyslipidemic patients: results of a phase IIb dose-ranging study.

Authors:  Christie M Ballantyne; Michael Miller; Eric J Niesor; Tracy Burgess; David Kallend; Evan A Stein
Journal:  Am Heart J       Date:  2012-03       Impact factor: 4.749

3.  High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (multi-ethnic study of atherosclerosis).

Authors:  Rachel H Mackey; Philip Greenland; David C Goff; Donald Lloyd-Jones; Christopher T Sibley; Samia Mora
Journal:  J Am Coll Cardiol       Date:  2012-07-11       Impact factor: 24.094

4.  The anti-oxidative capacity of high-density lipoprotein is reduced in acute coronary syndrome but not in stable coronary artery disease.

Authors:  Parin J Patel; Amit V Khera; Kashif Jafri; Robert L Wilensky; Daniel J Rader
Journal:  J Am Coll Cardiol       Date:  2011-11-08       Impact factor: 24.094

5.  Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.

Authors:  Amit V Khera; Marina Cuchel; Margarita de la Llera-Moya; Amrith Rodrigues; Megan F Burke; Kashif Jafri; Benjamin C French; Julie A Phillips; Megan L Mucksavage; Robert L Wilensky; Emile R Mohler; George H Rothblat; Daniel J Rader
Journal:  N Engl J Med       Date:  2011-01-13       Impact factor: 91.245

6.  Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial.

Authors:  James D Otvos; Dorothea Collins; David S Freedman; Irina Shalaurova; Ernst J Schaefer; Judith R McNamara; Hanna E Bloomfield; Sander J Robins
Journal:  Circulation       Date:  2006-03-13       Impact factor: 29.690

7.  High-density lipoprotein particle size and concentration and coronary risk.

Authors:  Karim El Harchaoui; Benoit J Arsenault; Remco Franssen; Jean-Pierre Després; G Kees Hovingh; Erik S G Stroes; James D Otvos; Nicholas J Wareham; John J P Kastelein; Kay-Tee Khaw; S Matthijs Boekholdt
Journal:  Ann Intern Med       Date:  2009-01-20       Impact factor: 25.391

8.  Large-scale candidate gene analysis of HDL particle features.

Authors:  Bernhard M Kaess; Maciej Tomaszewski; Peter S Braund; Klaus Stark; Suzanne Rafelt; Marcus Fischer; Robert Hardwick; Christopher P Nelson; Radoslaw Debiec; Fritz Huber; Werner Kremer; Hans Robert Kalbitzer; Lynda M Rose; Daniel I Chasman; Jemma Hopewell; Robert Clarke; Paul R Burton; Martin D Tobin; Christian Hengstenberg; Nilesh J Samani
Journal:  PLoS One       Date:  2011-01-21       Impact factor: 3.240

9.  Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study.

Authors:  Benjamin F Voight; Gina M Peloso; Marju Orho-Melander; Ruth Frikke-Schmidt; Maja Barbalic; Majken K Jensen; George Hindy; Hilma Hólm; Eric L Ding; Toby Johnson; Heribert Schunkert; Nilesh J Samani; Robert Clarke; Jemma C Hopewell; John F Thompson; Mingyao Li; Gudmar Thorleifsson; Christopher Newton-Cheh; Kiran Musunuru; James P Pirruccello; Danish Saleheen; Li Chen; Alexandre F R Stewart; Arne Schillert; Unnur Thorsteinsdottir; Gudmundur Thorgeirsson; Sonia Anand; James C Engert; Thomas Morgan; John Spertus; Monika Stoll; Klaus Berger; Nicola Martinelli; Domenico Girelli; Pascal P McKeown; Christopher C Patterson; Stephen E Epstein; Joseph Devaney; Mary-Susan Burnett; Vincent Mooser; Samuli Ripatti; Ida Surakka; Markku S Nieminen; Juha Sinisalo; Marja-Liisa Lokki; Markus Perola; Aki Havulinna; Ulf de Faire; Bruna Gigante; Erik Ingelsson; Tanja Zeller; Philipp Wild; Paul I W de Bakker; Olaf H Klungel; Anke-Hilse Maitland-van der Zee; Bas J M Peters; Anthonius de Boer; Diederick E Grobbee; Pieter W Kamphuisen; Vera H M Deneer; Clara C Elbers; N Charlotte Onland-Moret; Marten H Hofker; Cisca Wijmenga; W M Monique Verschuren; Jolanda M A Boer; Yvonne T van der Schouw; Asif Rasheed; Philippe Frossard; Serkalem Demissie; Cristen Willer; Ron Do; Jose M Ordovas; Gonçalo R Abecasis; Michael Boehnke; Karen L Mohlke; Mark J Daly; Candace Guiducci; Noël P Burtt; Aarti Surti; Elena Gonzalez; Shaun Purcell; Stacey Gabriel; Jaume Marrugat; John Peden; Jeanette Erdmann; Patrick Diemert; Christina Willenborg; Inke R König; Marcus Fischer; Christian Hengstenberg; Andreas Ziegler; Ian Buysschaert; Diether Lambrechts; Frans Van de Werf; Keith A Fox; Nour Eddine El Mokhtari; Diana Rubin; Jürgen Schrezenmeir; Stefan Schreiber; Arne Schäfer; John Danesh; Stefan Blankenberg; Robert Roberts; Ruth McPherson; Hugh Watkins; Alistair S Hall; Kim Overvad; Eric Rimm; Eric Boerwinkle; Anne Tybjaerg-Hansen; L Adrienne Cupples; Muredach P Reilly; Olle Melander; Pier M Mannucci; Diego Ardissino; David Siscovick; Roberto Elosua; Kari Stefansson; Christopher J O'Donnell; Veikko Salomaa; Daniel J Rader; Leena Peltonen; Stephen M Schwartz; David Altshuler; Sekar Kathiresan
Journal:  Lancet       Date:  2012-05-17       Impact factor: 79.321
  9 in total
  3 in total

Review 1.  HDL cholesterol studies--more of the same?

Authors:  Jean-Pierre Després
Journal:  Nat Rev Cardiol       Date:  2013-01-15       Impact factor: 32.419

2.  CANHEART: Is HDL cholesterol a cardiovascular specific risk factor?

Authors:  Mohamed Hassan; Peter Philip
Journal:  Glob Cardiol Sci Pract       Date:  2016-12-30

3.  Association Between HDL Cholesterol and QTc Interval: A Population-Based Epidemiological Study.

Authors:  Rosaria Del Giorno; Sofia Gabutti; Chiara Troiani; Kevyn Stefanelli; Raffaele Falciano; Elisa Graziano; Tommaso Rochat Negro; Luca Gabutti
Journal:  J Clin Med       Date:  2019-09-23       Impact factor: 4.241
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.